Vancomycin in the treatment of inflammatory bowel disease: there is a role beyond Clostridioides difficile infection

Simple item page
dc.coverageDOI: 10.17235/reed.2023.9942/2023
dc.creatorCalderón, Paula
dc.creatorDamas, Oriana M.
dc.creatorNúñez, Paulina
dc.creatorQuera, Rodrigo
dc.date2024
dc.date.accessioned05-01-2026 18:06
dc.date.available05-01-2026 18:06
dc.description<p>The development of new biological agents and small molecules has revolutionized the treatment of Inflammatory Bowel Disease (IBD). However, many patients do not respond or gradually lose their response, necessitating the search for other therapeutic strategies (1). In this clinical case, we describe the evolution of a patient with difficult-to-manage Crohn's Disease (CD) who was treated with oral vancomycin.</p>eng
dc.identifierhttps://investigadores.uandes.cl/en/publications/e814ebb5-ae74-46c2-858a-131b3c191016
dc.languageeng
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.sourcevol.116 (2024) nr.9 p.500-501
dc.subjectDysbiosis
dc.subjectInflammatory bowel disease
dc.subjectTreatment
dc.subjectVancomycin
dc.titleVancomycin in the treatment of inflammatory bowel disease: there is a role beyond Clostridioides difficile infectioneng
dc.typeLettereng
dc.typeCartaspa
Files
Collections
Escuela de Psicología